The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025.

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Messenger RNAs (mRNAs) work with DNA molecules to make our bodies function properly. They carry the genetic information stored in DNA and translate them into proteins, which help control cell division ...

Given the rise of artificial intelligence (AI) in the biotechnology industry in the last few years, it is no surprise that AI specialists represent a career in high demand right now – a trend that ...

Aelix Therapeutics is a clinical-stage biotech company based in Barcelona, in the northeast of Spain. It is a spin-off of IrsiCaixa, a Catalan organization founded to address the HIV/AIDS epidemic, ...

It’s summertime and what’s better than to curl up in bed, or under a shady tree, or by the pool, and read a good book? We have curated a list of some of the best biotech books that are bound to get ...

The BIO International Convention 2025, held in Boston this June, once again underscored the region’s leading role in the global biotech landscape. As thousands of industry leaders gathered to exchange ...